Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-16-569203
Filing Date
2016-04-29
Accepted
2016-04-29 16:05:10
Documents
4
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d189111d10ka.htm 10-K/A 428052
2 EX-31.1 d189111dex311.htm EX-31.1 7524
3 EX-31.2 d189111dex312.htm EX-31.2 7527
4 EX-32.1 d189111dex321.htm EX-32.1 7059
  Complete submission text file 0001193125-16-569203.txt   451201
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-33415 | Film No.: 161606491
SIC: 2834 Pharmaceutical Preparations